Mounts Bay Medical Limited

Contents

Balance Sheet	1 to 2
Notes to the Financial Statements	3 to 6

Mounts Bay Medical Limited

Balance Sheet

30 September 2025

	Note	2025 £	2024 £
Fixed assets
Tangible assets	4	10,943	11,550
Current assets
Debtors	5	242,768	222,595
Cash at bank and in hand		139,023	123,684
		381,791	346,279
Creditors: Amounts falling due within one year	6	(222,997)	(174,987)
Net current assets		158,794	171,292
Total assets less current liabilities		169,737	182,842
Provisions for liabilities		(2,736)	(2,121)
Net assets		167,001	180,721
Capital and reserves
Called up share capital		45,000	45,000
Share premium reserve		84,500	84,500
Capital redemption reserve		15,000	15,000
Profit and loss account		22,501	36,221
Shareholders' funds		167,001	180,721

Mounts Bay Medical Limited

Balance Sheet

30 September 2025

For the financial year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006 and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 26 June 2026 and signed on its behalf by:
 

......................................... Dr Christopher Martin Whitworth Director

......................................... Dr Stewart Ferguson Rutherfurd Director

Company Registration Number: 07842395

Mounts Bay Medical Limited

Notes to the Financial Statements

Year Ended 30 September 2025

1	General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Connor Downs Surgery
Turnpike Road
Connor Downs
Hayle
Cornwall
TR27 5DT

These financial statements were authorised for issue by the Board on 26 June 2026.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' including Section 1a and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Mounts Bay Medical Limited

Notes to the Financial Statements

Year Ended 30 September 2025

Deferred tax is recognised on all timing differences at the balance sheet date unless indicated below. Timing differences are differences between taxable profits and the results as stated in the profit and loss account and other comprehensive income. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Office equipment	20% reducing balance

Financial instruments

Classification
The company holds the following financial instruments:

• Short term trade and other debtors and creditors; and
• Cash and bank balances.

All financial instruments are classified as basic.

 Recognition and measurement
The company has chosen to apply the recognition and measurement principles in FRS102.

Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument and derecognised when in the case of assets, the contractual rights to cash flows from the assets expire or substantially all the risks and rewards of ownership are transferred to another party, or in the case of liabilities, when the company’s obligations are discharged, expire or are cancelled.

 

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2024 - 0).

Mounts Bay Medical Limited

Notes to the Financial Statements

Year Ended 30 September 2025

4	Tangible assets

	Furniture, fittings and equipment  £	Total £
Cost or valuation
At 1 October 2024	31,297	31,297
Additions	1,869	1,869
At 30 September 2025	33,166	33,166
Depreciation
At 1 October 2024	19,747	19,747
Charge for the year	2,476	2,476
At 30 September 2025	22,223	22,223
Carrying amount
At 30 September 2025	10,943	10,943
At 30 September 2024	11,550	11,550

5

Debtors

	2025 £	2024 £
Trade debtors	236,864	216,969
Prepayments	3,080	5,626
Other debtors	2,824	-
	242,768	222,595

Mounts Bay Medical Limited

Notes to the Financial Statements

Year Ended 30 September 2025

6

Creditors

Creditors: amounts falling due within one year

	2025 £	2024 £
Due within one year
Trade creditors	44,007	2,582
Taxation and social security	-	4,201
Accruals and deferred income	2,975	2,664
Other creditors	176,015	165,540
	222,997	174,987